// App-Quantinova.ai

: Identification and PK/PD Assessment of an Oral, Selective, avb6/ avb1 Dual Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • S. Turner

Principal Investigators

  • E. I. Lepist

  • F. Rock

  • M. Decaris

  • J. Schaub

  • C. Chen

  • P. Andre

Medical Centers

  • Denali Therapeutics South San Francisco CA United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved